ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2035

Performance of Icbd (International Criteria for Behcet’s Disease) in Iranian Children with Behcet’s Disease

Nahid Shafaie1, Bahar Sadeghi Abdollahi2 and Fereydoun Davatchi2, 1Rheumatology Research Centre, Shariati Hospital-Tehran Univ, Tehran, Iran, 2Rheumatology, Behcet's Unit, Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Behcet's syndrome and pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose:

ICBD is the new international criteria for diagnosis/classification of Behcet’s Disease, created in 2006. The scoring system for ICBD depends on 2 points for ocular lesions and genital ulcers each, and 1 point for each of oral aphtosis; skin manifestations; vascular manifestations; and positive-pathergy test. Three or more points are required to consider the patient as a case of Behcet’s Disease. The validity of the criteria has been confirmed for Iranian patients in 2010. To determine the performance of ICBD in Iranian children with Behcet’s Disease (Diagnosed before the age of 16), the sensitivity of ICBD is compared with 4 most commonly used diagnosis/classification criteria (Revised Japan, O’Duffy, International Study Group [ISG] and Classification Tree).

Methods:

According to the data registry for Behcet’s Disease patients in Rheumatology Research Center, Tehran University of Medical Sciences, Iran, all the patients diagnosed before the age of 16 (during 1975-2011) are included in the study. The fulfillment of each of the 5 criteria is evaluated for each patient and the sensitivity of different sets of criteria in childhood BD is calculated.

Results:

180 children out of 6813 BD patients (2.64 %, CI: 0.4) are selected (86 male and 94 female). The mean age was 10.7 years (SD: 3.4, CI: 0.5), mean duration 8.2 years (SD: 6.7), mean follow up 5 years (SD: 6.2) and the diagnosis delay 3.2 years (SD: 2.7).

I) 174 patients fulfilled the ICBD criteria (sensitivity 96.66%); 171 patients met Classification Tree criteria (sensitivity 95%); 156 patients for Revised Japan criteria (sensitivity 86.66%); 126 patients met ISG criteria (sensitivity 70%) and 103 patients fulfilled O’Duffy criteria with sensitivity of 57.2%.

II) Although the majority of the patients met all 5 sets of criteria, some of the patients could fulfill different combinations of criteria sets as described below;

88 patients (48.88%) met all 5 criteria; 30 patients (16.66%) fulfilled ICBD, Japan and Classification Tree; 26 patients (14.44%) met all the assessed criteria except for O’Duffy ; 7 patients (3.9%)  met all the assessed criteria except for ISG;  6 patients (3.33%)  could meet only ICBD and Classification Tree ; 6 patients (3.33%) met ICBD, Classification Tree and ISG;  5 patients (2.77%) met all the assessed criteria except for Japan; 3 patients (1.66 %) fulfilled ICBD and Japan Criteria;  2 patients (1.1 %) fulfilled ICBD, O’Duffy and Classification Tree; 2 patients (1.1 %) fulfilled ICBD, Japan and O’Duffy; 1 patient (1.1%) met ISG and Classification Tree and  4 patients (2.22 %) could not meet any of the 5 assessed criteria.

Conclusion:

The most sensitive criteria for Iranian children with Behcet’s disease was ICBD, followed by Classification Tree, Japan and ISG and O’Duffy. The higher sensitivity in ICBD, Classification Tree and Japan criteria may be explained by the prominence of the eye involvement in children and the importance of ocular lesions in these criteria sets.


Disclosure:

N. Shafaie,
None;

B. Sadeghi Abdollahi,
None;

F. Davatchi,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/performance-of-icbd-international-criteria-for-behcets-disease-in-iranian-children-with-behcets-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology